tradingkey.logo
tradingkey.logo

Lb Pharmaceuticals Initiates Pivotal Phase 3 Trial (Nova-2) For Lb-102 In Patients With Schizophrenia

ReutersMar 25, 2026 12:31 PM

LB Pharmaceuticals Inc LBRX.O:

  • LB PHARMACEUTICALS INITIATES PIVOTAL PHASE 3 TRIAL (NOVA-2) FOR LB-102 IN PATIENTS WITH SCHIZOPHRENIA

  • LB PHARMACEUTICALS INC - TOPLINE DATA EXPECTED IN SECOND HALF OF 2027

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI